Intriguingly, enhanced PD-L1 expression was also detected in CD45− cells in shUSP12 tumours (Fig. 5c), indicating a role of USP12 in modulating this immunoregulatory molecule in tumour cells and non-hematopoietic stromal cells in vivo. This evidence concerns the gene PTPRC and neoplasm.